| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 31-Dec-08 | | Total Revenue | 190,539 | 174,134 | 135,359 | 196,286 | | Cost of Revenue | 165,347 | 152,000 | 120,757 | 171,181 | | | Gross Profit | 25,192 | 22,134 | 14,602 | 25,105 | | | Operating Expenses | | Research Development | 1,720 | 1,525 | 1,695 | 1,633 | | Selling General and Administrative | 21,468 | 18,940 | 24,299 | 29,063 | | Non Recurring |
-
| 3,230 |
-
| (1,059) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (550) | (1,561) | (11,392) | (4,532) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 370 | | Earnings Before Interest And Taxes | (1,369) | (1,561) | (11,392) | (4,162) | | Interest Expense | (597) | 271 | 326 | 841 | | Income Before Tax | (772) | (1,832) | (11,718) | (5,003) | | Income Tax Expense | (898) | (1,046) | (3,574) | (1,698) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 126 | (786) | (8,144) | (3,305) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 126 | (786) | (8,144) | (3,305) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $126 | ($786) | ($8,144) | ($3,305) |
|
0.28% Nasdaq 
Income Statement
